Dysbetalipoproteinemia

DBCOND0022726Congenital, Hereditary, and Neonatal Diseases and AbnormalitiesNutritional and Metabolic Diseases

Dysbetalipoproteinemia is the indication for 3 drugs in DrugBank. It is covered by 3 curated, structured indications.

Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHT020885SNOMED CT398796005MedDRA10038316UMLSC0020479

What you can answer from here — as of October 22, 2026

3Indicated drugsWith each drug's targets and mechanism
Listed above
3Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which approved drugs for Dysbetalipoproteinemia share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In